- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03167996
Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology (HealthPals)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will use telemedicine and the mobile health capabilities of smartphones to facilitate communication of medical goals set by the treating physician to the subject in between clinic visits, and to assess the daily medical and lifestyle change compliance of enrolled Stanford subjects and provide virtual health coaching, as needed, to subjects to achieve said goals. How patients comply with their specific medical and lifestyle goals all affect their cardiovascular health, yet largely go unmeasured. These can now be measured with a notification-based system in which subject-entered activity, medication compliance, and dietary reporting data will be collected, assessed, and trigger appropriate responses by the subject's Care Team, which includes their physician, nurse, dietitian, and assigned health coach. We aim to collect this subject-reported activity and cardiovascular care plan compliance data to provide much more quantitative data on type, duration, and intensity of daily activities and compliance with the medication regimens of enrolled subjects.
The study will compare anthropometric cardiovascular risk biomarkers testing at the initial visit and after 3 months, in subjects utilizing the HealthPals digital platform PLUS the standard SSATHI clinic visits, versus subjects receiving only SSATHI clinic visits.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adult smartphone users
Exclusion Criteria:
- Subjects who do not own a smartphone or cannot access their mobile health data
- Patients unable to read English, as the initial version of the research app will be in English
- Participants who are children (under 18 years old)
- Participants who are pregnant women
- Participants who are economically and educationally disadvantaged, decisionally impaired, homeless people, or employees of Stanford University will be excluded due to being of a vulnerable population.
- Participants who express active chest pain or shortness of breath in their first clinic visit and are clinically deemed to require an emergency room evaluation will be excluded
- Participants who have inability or unwillingness to use or connect to data services for app messaging
- Participants with an upcoming surgical procedure (for instance, a clinic visit as part of preoperative evaluation) that will significantly impair or block their ability to follow the chronic disease management program during the study period
- Participants who have pre-existing participation in another clinical research protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Group B/ HealthPals
Group B have access to HealthPals app where they will coordinate with a trained health coach Group B patients will only come into SSATHI clinic to see their doctor for an initial visit and 6 month follow up, and they will have a telephone visit with their doctor at 3 months instead of an in-clinic visit Lab testing is the same for both Group A/ control and Group B patients |
HealthPals is a smartphone-based chronic disease management mobile application. It uses the mobile health capabilities of smartphones to provide a secure communication portal for patients with their Care Teams to help achieve cardiovascular risk reduction through a digital health coach-based coaching for lifestyle and medication compliance. The HealthPals app was developed by HealthPals, Inc. |
|
NO_INTERVENTION: Group A/ Control
Group B will not have access to HealthPals app Group A patients will come into SSATHI clinic to see their doctor for an initial visit, a 3 month follow up, and a 6 month follow up Lab testing is the same for both Group A/ control and Group B patients |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in exercise activity over 6 months
Time Frame: 6 months or through study completion
|
Patients are given exercise recommendations (or physical activity goals depending on the patient's capacity for exercise) at the time of the initial visit by the HealthPals health coach.
The patients will input their activity into the HealthPals platform at time points of their convenience during their 6 month involvement in the study, and this data will be securely aggregated within the platform.
The HealthPals health coach who has access to this data will compile and analyze the data and also send it back to the patients' providers by means of final health reports, assessing the change of exercise activity over the duration of the patient's involvement in the study.
|
6 months or through study completion
|
|
Measuring medication compliance
Time Frame: Monthly assessment and report for duration of their involvement in the study
|
The patients will input their compliance to their medication regimen into the HealthPals platform at time points of their convenience, and this data will be securely aggregated within the platform.
The HealthPals health coach who has access to this data will compile and analyze the data and also send it back to the patients' providers by means of final reports.
|
Monthly assessment and report for duration of their involvement in the study
|
|
Measuring trends in Blood Pressure measurements
Time Frame: Monthly assessment and report for duration of their involvement in the study
|
The patients will input their blood pressure in mmHg at time points of their convenience into the HealthPals platform, and this data will be securely aggregated within the platform.
The HealthPals health coach who has access to this data will compile and analyze the data and also send it back to the patients' providers by means of monthly health reports.
|
Monthly assessment and report for duration of their involvement in the study
|
|
Measuring trends in weight measurements
Time Frame: Monthly assessment and report for duration of their involvement in the study
|
The patients will input their weight in kg at time points of their convenience into the HealthPals platform, and this data will be securely aggregated within the platform.
The HealthPals health coach who has access to this data will compile and analyze the data and also send it back to the patients' providers by means of monthly health reports.
|
Monthly assessment and report for duration of their involvement in the study
|
|
Measuring compliance to dietary recommendations
Time Frame: Monthly assessment and report for duration of their involvement in the study
|
Patients are given dietary recommendations at the time of their initial visit by the HealthPals health coach.
After the first visit the patients will input their diet into the HealthPals platform at time points of their convenience, and this data will be securely aggregated within the platform.
The HealthPals health coach who has access to this data will compile and analyze the data and also send it back to the patients' providers by means of monthly health reports.
|
Monthly assessment and report for duration of their involvement in the study
|
|
Initial User Assessment
Time Frame: Questionnaire administered at time of initial visit
|
Questionnaire covering personal history, family history, typical diet, exercise and activity, and stress level quantification.
This questionnaire is used for a baseline analysis of the patients' health status by the HealthPals health coach.
|
Questionnaire administered at time of initial visit
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Fahim Abbasi, MD, Stanford University
- Principal Investigator: Shriram Nallamshetty, MD, Stanford University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Glucose Metabolism Disorders
- Metabolic Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Hyperinsulinism
- Coronary Disease
- Lipid Metabolism Disorders
- Coronary Artery Disease
- Prehypertension
- Dyslipidemias
- Insulin Resistance
Other Study ID Numbers
- 36464
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
Clinical Trials on Use of HealthPals (Telemedicine supported by digital health platform)
-
Kirsehir Ahi Evran UniversitesiNot yet recruitingDigital Storytelling
-
Shanxi Bethune HospitalRecruitingDiabetes Mellitus, Type 2 | Telemedicine | Digital Health | Chronic Disease Management | Integrated Traditional Chinese Medicine and Western MedicineChina
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
University of Alabama at BirminghamPatient-Centered Outcomes Research InstituteNot yet recruiting
-
Centre for Chronic Disease Control, IndiaUniversity of Leicester; Kathmandu Medical College and Teaching Hospital; All...Not yet recruitingChronic Conditions, Multiple | Endocrine, Nutritional and Metabolic Diseases | Diseases of the Eye and Adnexa | Diseases of the Ear and Mastoid Process | Diseases of the Circulatory System | Diseases of the Respiratory System | Diseases of the Musculoskeletal System and Connective Tissue | Mental...India, Nepal
-
University of AberdeenCompletedCancer | Sickle Cell Disease | Immunosuppression | Inborn Errors of Metabolism | Organ Transplant | COPD AsthmaUnited Kingdom
-
National University Heart Centre, SingaporeActive, not recruitingAcute Myocardial Infarction (AMI)Singapore
-
University of Alabama at BirminghamNational Institute on Minority Health and Health Disparities (NIMHD); University... and other collaboratorsActive, not recruitingDiabetes Mellitus, Type 2United States
-
Instituto Mexicano del Seguro SocialNot yet recruitingSubacromial Impingement Syndrome
-
Helse Møre og Romsdal HFSINTEF Health Research; Kristiansund municipality; Centre for Health Innovation; Hospital Pharmacy of Central Norway TrustRecruiting